{"id":"intramuscular-midazolam","safety":{"commonSideEffects":[{"rate":null,"effect":"Drowsiness and sedation"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Injection site reactions"}]},"_chembl":{"chemblId":"CHEMBL655","moleculeType":"Small molecule","molecularWeight":"325.77"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Midazolam binds to GABA-A receptors and potentiates the effect of the inhibitory neurotransmitter GABA, leading to increased chloride ion influx and neuronal hyperpolarization. This results in depression of the central nervous system with sedative, anxiolytic, anticonvulsant, and muscle relaxant properties. When administered intramuscularly, it provides rapid onset of action suitable for acute sedation and anxiety management.","oneSentence":"Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at GABA-A receptors in the central nervous system, producing sedation, anxiolysis, and muscle relaxation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:49:32.509Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute anxiety and agitation"},{"name":"Preoperative sedation and anxiolysis"},{"name":"Acute seizure management"},{"name":"Sedation in critical care settings"}]},"trialDetails":[{"nctId":"NCT05121324","phase":"PHASE3","title":"Pediatric Dose Optimization for Seizures in Emergency Medical Services","status":"RECRUITING","sponsor":"Stanford University","startDate":"2022-08-08","conditions":"Seizures","enrollment":6700},{"nctId":"NCT07095842","phase":"PHASE2, PHASE3","title":"Prehospital Early Administration of Ketamine for Status Epilepticus in Epileptic Kids (PEAK-SEEK)","status":"RECRUITING","sponsor":"Sohag University","startDate":"2025-08-03","conditions":"Convulsive Status EPILEPTICUS","enrollment":668},{"nctId":"NCT02461927","phase":"PHASE1, PHASE2","title":"Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2015-01-01","conditions":"Major Depressive Disorder, Alcohol Use Disorder","enrollment":65},{"nctId":"NCT01296555","phase":"PHASE1","title":"A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer","status":"TERMINATED","sponsor":"Genentech, Inc.","startDate":"2011-03-16","conditions":"Solid Cancers, Non-Hodgkin's Lymphoma","enrollment":674},{"nctId":"NCT02078336","phase":"PHASE4","title":"Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2013-12","conditions":"Dental Care for Disabled","enrollment":40},{"nctId":"NCT05324852","phase":"PHASE3","title":"AGItated Patients Management: intraNASAL Midazolam vs Intramuscular Loxapine","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-04-09","conditions":"Emergence Delirium","enrollment":1},{"nctId":"NCT06271096","phase":"EARLY_PHASE1","title":"Intramuscular Midazolam Versus Intravenous Diazepam for Acute Seizure in Children","status":"COMPLETED","sponsor":"Arooj Khan","startDate":"2019-11-01","conditions":"Seizures","enrollment":150},{"nctId":"NCT05670509","phase":"PHASE4","title":"Intranasal vs Buccal vs Intramuscular Midazolam for the Home and Emergency Treatment of Acute Seizures","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2019-01-19","conditions":"Convulsions","enrollment":305},{"nctId":"NCT02380118","phase":"PHASE4","title":"IM Olanzapine Versus Haloperidol or Midazolam","status":"TERMINATED","sponsor":"The University of Hong Kong","startDate":"2014-12","conditions":"Acute Agitation, Behavioural Emergency","enrollment":167},{"nctId":"NCT05026567","phase":"PHASE1","title":"Bioavailability Study of Midazolam Administered as a Solution by Conventional Syringe or ZENEO®","status":"COMPLETED","sponsor":"Crossject","startDate":"2022-05-09","conditions":"Healthy","enrollment":40},{"nctId":"NCT04679623","phase":"PHASE1","title":"Study of Midazolam in Healthy Adults","status":"COMPLETED","sponsor":"Rafa Laboratories","startDate":"2021-06-09","conditions":"Status Epilepticus","enrollment":40},{"nctId":"NCT02401074","phase":"PHASE1","title":"Airway Temperature","status":"WITHDRAWN","sponsor":"Lu Yuan Lee","startDate":"2018-11-08","conditions":"Asthma","enrollment":""},{"nctId":"NCT02897856","phase":"PHASE4","title":"Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures","status":"COMPLETED","sponsor":"Hamad Medical Corporation","startDate":"2016-09","conditions":"Seizures","enrollment":150},{"nctId":"NCT03554915","phase":"","title":"Ketamine Versus Midazolam for Prehospital Agitation","status":"COMPLETED","sponsor":"Hennepin Healthcare Research Institute","startDate":"2017-08-01","conditions":"Agitation","enrollment":314},{"nctId":"NCT03860831","phase":"PHASE1","title":"Intranasal Ketamine and Midazolam Mixture for Procedural Sedation in Children With Mental Disabilities:","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2019-03-06","conditions":"Procedural Sedation","enrollment":40},{"nctId":"NCT03042572","phase":"PHASE2, PHASE3","title":"Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs","status":"UNKNOWN","sponsor":"Martin Teraa, MD, PhD","startDate":"2018-12","conditions":"Peripheral Arterial Disease, Cardiovascular Diseases, Vascular Diseases","enrollment":60},{"nctId":"NCT03211897","phase":"","title":"Olanzapine, Haloperidol, Ziprasidone, Midazolam for Acute Undifferentiated Agitation","status":"COMPLETED","sponsor":"Hennepin Healthcare Research Institute","startDate":"2017-06-15","conditions":"Agitation,Psychomotor","enrollment":737},{"nctId":"NCT01371110","phase":"PHASE1, PHASE2","title":"Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder","status":"TERMINATED","sponsor":"Wayne Goodman MD","startDate":"2012-06","conditions":"Obsessive Compulsive Disorder","enrollment":3},{"nctId":"NCT03325335","phase":"NA","title":"Assessing the Effectiveness of Midazolam Premedication","status":"COMPLETED","sponsor":"Pusan National University Hospital","startDate":"2016-07-19","conditions":"Midazolam Premedication, Anxiety Preoperative, Premedication","enrollment":128},{"nctId":"NCT02479581","phase":"PHASE2","title":"The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS)Applied on Cardiac Surgery With Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Xiangya Hospital of Central South University","startDate":"2015-07","conditions":"Valvular Heart Disease","enrollment":226},{"nctId":"NCT00809146","phase":"PHASE3","title":"Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications","status":"COMPLETED","sponsor":"Robert Silbergleit","startDate":"2009-06","conditions":"Status Epilepticus","enrollment":1023},{"nctId":"NCT02658721","phase":"PHASE3","title":"Effects of Systemic or Adjunct Tramadol Addition to Lidocaine Used for IVRA in Patients Undergoing Hand Surgery","status":"COMPLETED","sponsor":"Bagcilar Training and Research Hospital","startDate":"2013-01","conditions":"Anesthesia","enrollment":60},{"nctId":"NCT02313337","phase":"PHASE4","title":"The Comparison of Different Administration Routes of Pediatric Premedication","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2014-12","conditions":"Anesthesia","enrollment":80},{"nctId":"NCT02117401","phase":"PHASE4","title":"A Prospective, Multi-center, Randomized Controlled Study of Muscle Relaxation Effect and Safety of Mivacurium Chloride in Pediatric Surgery Patients","status":"COMPLETED","sponsor":"Jiangsu Nhwa Pharmaceutical Co., Ltd.","startDate":"2012-01","conditions":"Efficacy and Safety of Mivacurium Chloride for Pediatric Patients","enrollment":1152},{"nctId":"NCT01754116","phase":"PHASE1","title":"A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2013-01","conditions":"Infection, Human Immunodeficiency Virus","enrollment":43},{"nctId":"NCT01937611","phase":"PHASE4","title":"Intramuscular Dexmedetomidine as Premedication","status":"UNKNOWN","sponsor":"Guangzhou First People's Hospital","startDate":"2013-03","conditions":"Laryngoscopy, Preanesthetic Medication","enrollment":40},{"nctId":"NCT01485692","phase":"NA","title":"Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy Evaluation","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2009-02","conditions":"Psychomotor Agitation","enrollment":120},{"nctId":"NCT01066247","phase":"NA","title":"Premedication and Haemodynamics After Spinal Anesthesia","status":"COMPLETED","sponsor":"Medical University of Gdansk","startDate":"2009-09","conditions":"Hemodynamics After Spinal Anesthesia","enrollment":60},{"nctId":"NCT00534378","phase":"PHASE1","title":"Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector","status":"COMPLETED","sponsor":"U.S. Army Office of the Surgeon General","startDate":"2006-07","conditions":"Seizures","enrollment":39}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Intramuscular midazolam","genericName":"Intramuscular midazolam","companyName":"Hamad Medical Corporation","companyId":"hamad-medical-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at GABA-A receptors in the central nervous system, producing sedation, anxiolysis, and muscle relaxation. Used for Acute anxiety and agitation, Preoperative sedation and anxiolysis, Acute seizure management.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}